Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2600

1.

Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.

Tsegaye A, Wolday D, Otto S, Petros B, Assefa T, Alebachew T, Hailu E, Adugna F, Measho W, Dorigo W, Fontanet AL, van Baarle D, Miedema F.

Clin Immunol. 2003 Dec;109(3):338-46.

PMID:
14697749
2.

Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.

D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M.

Haematologica. 1998 Mar;83(3):197-203.

4.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55.

PMID:
12459356
5.

Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.

Plaeger-Marshall S, Hultin P, Bertolli J, O'Rourke S, Kobayashi R, Kobayashi AL, Giorgi JV, Bryson Y, Stiehm ER.

J Acquir Immune Defic Syndr. 1993 Sep;6(9):984-93.

PMID:
7688045
6.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

7.

Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.

Benito JM, Zabay JM, Gil J, Bermejo M, Escudero A, Sánchez E, Fernández-Cruz E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):128-35.

PMID:
9052721
8.

Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.

Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.

Clin Immunol. 2001 Feb;98(2):212-9.

PMID:
11161977
9.
10.

Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.

Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL.

Clin Exp Immunol. 1994 Mar;95(3):436-41.

11.

Characterization of lymphocyte subsets in rhesus macaques during the first year of life.

DeMaria MA, Casto M, O'Connell M, Johnson RP, Rosenzweig M.

Eur J Haematol. 2000 Oct;65(4):245-57.

PMID:
11073165
12.

Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.

Hudnall SD, Patel J, Schwab H, Martinez J.

Cytometry B Clin Cytom. 2003 Sep;55(1):22-8.

13.

Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

Rodrigues DS, Medeiros EA, Weckx LY, Bonnez W, Salomão R, Kallas EG.

Clin Exp Immunol. 2002 Apr;128(1):149-54.

14.

Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.

Bofill M, Mocroft A, Lipman M, Medina E, Borthwick NJ, Sabin CA, Timms A, Winter M, Baptista L, Johnson MA, Lee CA, Phillips AN, Janossy G.

AIDS. 1996 Jul;10(8):827-34.

PMID:
8828739
15.

HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.

Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):19-30.

PMID:
10534143
19.

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.

PMID:
15764953

Supplemental Content

Support Center